United Capital Financial Advisors LLC Makes New $9.88 Million Investment in Danaher Corporation $DHR

United Capital Financial Advisors LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 13,726 shares of the conglomerate’s stock, valued at approximately $9,884,000.

Several other institutional investors and hedge funds have also recently modified their holdings of DHR. BlackRock Inc. acquired a new position in Danaher in the 2nd quarter worth about $10,492,520,000. Norges Bank acquired a new stake in Danaher in the fourth quarter valued at approximately $2,177,106,000. Jupiter Topco LLC purchased a new stake in shares of Danaher in the second quarter valued at approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher during the 2nd quarter worth approximately $1,287,949,000. Finally, Bank of America Corp DE purchased a new position in shares of Danaher during the 2nd quarter valued at approximately $993,846,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Up 0.2%

Shares of DHR opened at $215.74 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. The stock has a market capitalization of $151.67 billion, a PE ratio of 38.32, a P/E/G ratio of 2.68 and a beta of 0.78. The company’s 50-day simple moving average is $198.69 and its 200-day simple moving average is $192.35. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. During the same period in the prior year, the business earned $0.77 EPS. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. Analysts forecast that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Analysts Set New Price Targets

DHR has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft reissued a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 22nd. Weiss Ratings upgraded shares of Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, July 15th. DZ Bank began coverage on shares of Danaher in a research note on Wednesday, June 3rd. They set a “buy” rating and a $210.00 target price for the company. Finally, Citigroup initiated coverage on shares of Danaher in a research report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.